BeOne Medicines (formerly BeiGene) sells cancer drugs globally, led by Brukinsa.
BeOne Medicines AG (ONC) is expected to report earnings on Thursday, November 5, 2026, before the open. Estimated release time 06:03 ET. Consensus EPS estimate is $1.89.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-05 | Jun 2026 qtr | $1.63 | $2.05 | +25.8% | $1.71B |
| 2026-05-06 | Mar 2026 qtr | $0.73 | $1.96 | — | $1.51B |
| 2026-02-26 | Dec 2025 qtr | $1.60 | $0.58 | — | $1.50B |
| 2025-11-06 | Sep 2025 qtr | $0.72 | $1.09 | — | $1.41B |
| 2025-08-06 | Jun 2025 qtr | $0.48 | $0.87 | — | $1.32B |
| 2025-03-31 | Mar 2025 qtr | $-0.88 | $0.01 | — | $1.12B |
| 2024-12-31 | Sep 2024 qtr | $-0.88 | $-1.43 | — | $1.13B |
| 2024-09-30 | Jun 2024 qtr | $-2.10 | $-1.16 | — | $1.00B |
ONC has beaten consensus EPS in 1 of its last 1 scored quarters.
See ONC on the live calendar →